If You Invested in Cannabix Technol (BLOZF)

Cannabix Technologies Inc. (OTC: BLOZF) is described in its public news releases as a developer of marijuana and alcohol breath technologies for workplaces, law enforcement and other settings. The company’s work focuses on breath testing for delta-9 THC, the primary psychoactive ingredient in cannabis, with an emphasis on detecting recent marijuana use rather than historical consumption.

Cannabix Technologies is associated with the symbols CSE: BLO, OTC: BLOZF and Frankfurt: 8CT in its news releases and is based in Vancouver, British Columbia. According to multiple company announcements, Cannabix develops hardware and systems intended to support workplace safety, transportation safety and public safety by enabling rapid breath-based screening for alcohol and cannabis.

Marijuana Breath Test (MBT) System

A central focus of Cannabix Technologies is its Marijuana Breath Test (MBT) solution. Company news describes the MBT hardware as incorporating a proprietary Breath Collection Unit (BCU) and Breath Cartridge (BC) technologies. These components are designed to collect and preserve breath samples for analysis using liquid chromatography–mass spectrometry (LC‑MS) methods to detect delta‑9‑tetrahydrocannabinol (Δ9‑THC) in breath.

The MBT system is described as targeting the detection of recent cannabis use, distinguishing it from urine, blood and saliva methods that can show THC exposure many hours, days or weeks after consumption. Cannabix has highlighted potential use cases for the MBT in workplaces and roadside screening environments, where identifying recent use is important for safety-related decisions.

According to company disclosures, Cannabix has a strategic partnership with Omega Laboratories Inc., an international forensic drug testing laboratory. Cannabix reports that it has delivered MBT units and Breath Cartridges to Omega to support implementation of breath testing within Omega’s laboratory-developed test methods and service offerings. The parties are described as collaborating on manufacturing, marketing, distribution, support and logistics for MBT deployment with selected clients in the U.S. and Canada.

BreathLogix Alcohol Screening Platform

In addition to cannabis-focused technology, Cannabix Technologies reports that it is the developer of the BreathLogix autonomous alcohol screening device. Company news describes BreathLogix as an unmanned alcohol screening system intended for environments where operational safety is critical, including sectors such as maritime, oil and gas transportation, mining, industrial operations, trucking and warehousing.

BreathLogix devices are described as providing rapid breath alcohol checks while simultaneously capturing a photo of the user to confirm and record identity. The system displays Blood Alcohol Content (BAC or BrAC) readings on-screen and sends real-time test reports via SMS and email to managers, with all test results logged and managed through a dedicated BreathLogix Connect web portal. Cannabix states that BreathLogix can be integrated with doors, turnstiles, gates, facial recognition systems, fingerprint readers and motor vehicle key fleet management systems for pre-access alcohol testing.

According to company announcements, the BreathLogix Workplace Series has been approved by the U.S. National Highway Traffic Safety Administration (NHTSA) to be added to the Federal Register Conforming Products List (CPL) for breath alcohol screening devices. Cannabix also notes that BreathLogix incorporates patent-pending pre-calibrated sensor cartridge technology designed to simplify device maintenance by reducing the need for specialized calibration equipment and on-site technician visits.

Contactless Breath Analysis and Intellectual Property

Cannabix Technologies reports that the United States Patent and Trademark Office has granted it a patent entitled “Contact-Free Breath Analysis Device and Method.” Company disclosures state that this patent relates to dual-mode contactless and traditional mouthpiece breath capture and analysis technology used in the BreathLogix platform.

The patent-related news describes technology that can be integrated into environments such as vehicles, workplaces or public kiosks, supporting fast testing without physical contact. The system is described as providing real-time feedback through visual indicators and displays, and as adjusting internal airflow and pump mechanisms based on the sampling method. Cannabix characterizes this design as suitable for applications in law enforcement, workplace safety and public health monitoring.

Regulatory and Compliance Milestones

In its news releases, Cannabix reports several regulatory and compliance steps related to its hardware. The company states that its handheld Breath Collection Unit (BCU) has passed electronic emissions testing required by the U.S. Federal Communications Commission (FCC) under CFR Title 47 FCC Part 15, and that testing was also completed in conformance with ICES‑003 Issue 7, a Canadian standard for electronic devices published by Innovation, Science and Economic Development Canada (ISED). Testing was conducted at QAI Laboratories in British Columbia, which is described as an ISO/IEC 17025 accredited lab recognized in both the U.S. and Canada for electrical safety evaluations and certification.

These emissions tests are presented by the company as key steps toward commercialization of the MBT hardware in U.S. and Canadian markets. Cannabix also notes participation in industry and standards-related events, such as a workshop hosted by the U.S. National Institute of Standards and Technology (NIST) focused on cannabis breathalyzer development, and the National Safety Council (NSC) Safety Congress & Expo, where it has exhibited MBT and BreathLogix devices with a distribution partner.

Market Applications and Partnerships

Across its announcements, Cannabix positions its technologies for use in workplaces, law enforcement and other safety-sensitive settings. The company highlights applications in maritime shipping, oil and gas transportation, mining, industrial operations, trucking and warehousing, where pre-access alcohol or cannabis screening can support operational safety. Cannabix has disclosed sales agreements for BreathLogix devices with a European maritime shipping customer and an oilfield transportation services company in northern Alberta, Canada.

The company also reports that its BreathLogix system is integrated with a cloud-based platform, BreathLogix Connect, which is described as being powered by Amazon Web Services and used for real-time alerts, centralized data management and reporting. In addition, Cannabix mentions the use of facial recognition technology in certain deployments to support rapid and secure user identification.

Position in the Breath Testing and Safety Technology Space

According to its public statements, Cannabix Technologies concentrates on breath-based detection technologies for both alcohol and cannabis, with an emphasis on recent-use THC detection. Its collaboration with Omega Laboratories and participation in regulatory and standards-oriented events indicate a focus on aligning its products with laboratory practices and regulatory frameworks relevant to forensic drug testing and workplace safety programs.

Investors and observers looking at BLOZF can use this context to understand that Cannabix’s disclosed activities center on the development, validation and commercialization of breath testing hardware and associated software platforms, rather than on resource extraction or traditional mining operations, despite industry classification references that may appear in some third-party data sources.

Frequently Asked Questions (FAQ)

• What does Cannabix Technologies Inc. do?
  According to its news releases, Cannabix Technologies Inc. develops marijuana and alcohol breath technologies for workplaces, law enforcement and other settings, focusing on breath testing for delta‑9 THC and alcohol.
• What is the Marijuana Breath Test (MBT) system?
  The MBT system is described by the company as a marijuana breath testing solution that uses a proprietary Breath Collection Unit and Breath Cartridges to collect and preserve breath samples for LC‑MS analysis of delta‑9‑THC, with an emphasis on detecting recent cannabis use.
• Who is Omega Laboratories and how is it connected to Cannabix?
  Cannabix states that Omega Laboratories Inc. is an international forensic drugs-of-abuse testing laboratory. The two parties have a strategic partnership and development agreement to advance commercialization of the MBT technology, including manufacturing, marketing, distribution and integration of breath testing into Omega’s services.
• What is BreathLogix?
  BreathLogix is described as Cannabix’s unmanned or autonomous alcohol screening device platform. It is designed for rapid breath alcohol checks, identity confirmation via user photos and integration with access control systems, with results managed through the BreathLogix Connect web portal.
• In which industries are Cannabix’s technologies intended to be used?
  Company announcements mention potential deployment of BreathLogix and related technologies in industries where safety is critical, including maritime, mining, oil and gas, industrial operations, trucking and warehousing, as well as broader workplace and law enforcement settings.
• What regulatory milestones has Cannabix reported?
  Cannabix reports that its Breath Collection Unit has passed FCC electronic emissions testing and Canadian ICES‑003 standards, and that its BreathLogix Workplace Series device has been approved by NHTSA for inclusion on the U.S. Federal Register Conforming Products List for breath alcohol screening devices.
• What intellectual property has Cannabix disclosed?
  The company reports that the United States Patent and Trademark Office granted it a patent titled “Contact-Free Breath Analysis Device and Method,” covering contactless and traditional mouthpiece breath capture and analysis technology used in the BreathLogix platform.
• Where is Cannabix Technologies based and on which markets is it quoted?
  Cannabix’s news releases identify it as a Vancouver, British Columbia–based company whose shares are associated with the symbols CSE: BLO, OTC: BLOZF and Frankfurt: 8CT.